Avastin Can Be Used Off Label For AMD, Says UK MHRA

 
• By Ian Schofield

The UK regulator has clarified its guidance on the use of the anticancer Avastin for age-related macular degeneration, saying that reformulating the drug into small vials for ophthalmic injection represents an off-label use of the Roche product and does not create an unlicensed medicine.

Human eye
The MHRA has changed its guidance on the use of Avastin in the eye

More from United Kingdom

More from Europe